Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) affects 13–20 people per 100,000 population worldwide. In the United States, approximately 100,000 people have IPF with 30,000–40,000 new cases diagnosed annually. Diagnosis remains a challenge with a significant lag between symptoms onset and diagnosis. Delayed d...
Uloženo v:
| Médium: | Online |
|---|---|
| Jazyk: | angličtina |
| Vydáno: |
IntechOpen
2023
|
| Témata: | |
| On-line přístup: | ONIX_20230215_9781839692406_199 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | Idiopathic pulmonary fibrosis (IPF) affects 13–20 people per 100,000 population worldwide. In the United States, approximately 100,000 people have IPF with 30,000–40,000 new cases diagnosed annually. Diagnosis remains a challenge with a significant lag between symptoms onset and diagnosis. Delayed diagnosis and treatment can carry high morbidity and mortality. This book provides concise, easy-to-read, and up-to-date information as it relates to clinical presentation, diagnosis, and treatment of IPF. Despite, adequate treatment, the disease progresses, and a lung transplant is necessary in some cases. This book also discusses the role of lung transplants for IPF and its complications. It is a useful resource for primary care physicians, allied health professionals, hospitalists, and pulmonary physicians who take care of patients with IPF. |
|---|